270 related articles for article (PubMed ID: 9887323)
1. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
Holzer GW; Mayrhofer JA; Gritschenberger W; Dorner F; Falkner FG
Virology; 1999 Jan; 253(1):107-14. PubMed ID: 9887323
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia viral/retroviral chimeric vectors.
Falkner FG; Holzer GW
Curr Gene Ther; 2004 Dec; 4(4):417-26. PubMed ID: 15578991
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.
Konetschny C; Holzer GW; Falkner FG
J Virol; 2002 Feb; 76(3):1236-43. PubMed ID: 11773399
[TBL] [Abstract][Full Text] [Related]
4. Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus.
Konetschny C; Holzer GW; Urban C; Hämmerle T; Mayrhofer J; Falkner FG
J Virol; 2003 Jun; 77(12):7017-25. PubMed ID: 12768020
[TBL] [Abstract][Full Text] [Related]
5. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
Tabotta W; Klein D; Hohenadl C; Salmons B; Günzburg WH
J Gene Med; 2001; 3(5):418-26. PubMed ID: 11601755
[TBL] [Abstract][Full Text] [Related]
6. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
7. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
Holzer GW; Falkner FG
Methods Mol Med; 2003; 76():565-78. PubMed ID: 12526185
[No Abstract] [Full Text] [Related]
8. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
[TBL] [Abstract][Full Text] [Related]
9. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
10. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
11. Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteins.
Himly M; Pfleiderer M; Holzer G; Fischer U; Hannak E; Falkner FG; Dorner F
Protein Expr Purif; 1998 Dec; 14(3):317-26. PubMed ID: 9882565
[TBL] [Abstract][Full Text] [Related]
12. Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system.
Dong J; Hunter E
Virology; 1993 May; 194(1):192-9. PubMed ID: 8386872
[TBL] [Abstract][Full Text] [Related]
13. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
Torrent C; Jullien C; Klatzmann D; Perricaudet M; Yeh P
Cancer Gene Ther; 2000 Aug; 7(8):1135-44. PubMed ID: 10975674
[TBL] [Abstract][Full Text] [Related]
14. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids regulate expression of the v-mycOK10 oncogene in a murine retroviral vector with chimeric MoMuLV-MMTV LTRs.
Jacquemin-Sablon H; Bogenberger J
Biochem Int; 1990; 20(4):669-79. PubMed ID: 2162166
[TBL] [Abstract][Full Text] [Related]
16. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors.
Ramsey WJ; Caplen NJ; Li Q; Higginbotham JN; Shah M; Blaese RM
Biochem Biophys Res Commun; 1998 May; 246(3):912-9. PubMed ID: 9618311
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
[TBL] [Abstract][Full Text] [Related]
20. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
Tolmachov O
Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]